Julie C. Sung
- Co-authors
- Gary GoldenbergLinda Stein‐GoldLeon KircikPonni PerumalswamiAndrea D. BranchCatherine OngMyron SchwartzDouglas T. Dieterich
- Topics
- Hepatitis C virus research (2 papers)Liver Disease Diagnosis and Treatment (2 papers)Liver Diseases and Immunity (1 paper)
- Cited by
- HepatologyEpidemiologyToxicology
- Journals
- Antimicrobial Agents and ChemotherapyJournal of Viral HepatitisClinical Liver Disease
- Partner nations
- United StatesSingaporeUnited Kingdom
In The Last Decade
Julie C. Sung
4 papers receiving 47 citations
Peers
Comparison fields: 5 of 36
- Epidemiology 22
- Hepatology 14
- Molecular Biology 12
- Endocrinology, Diabetes and Metabolism 6
- Dermatology 5
Countries citing papers authored by Julie C. Sung
This map shows the geographic impact of Julie C. Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Sung more than expected).
Fields of papers citing papers by Julie C. Sung
This network shows the impact of papers produced by Julie C. Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Sung. The network helps show where Julie C. Sung may publish in the future.
Co-authorship network of co-authors of Julie C. Sung
This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Sung. A scholar is included among the top collaborators of Julie C. Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Sung. Julie C. Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | United States Food and Drug Administration Product Label Changes. | 12 |
| 4 | 23 |
About Julie C. Sung
Julie C. Sung is a scholar working on Toxicology, Hepatology and Molecular Medicine, having authored 4 papers that have together received 49 indexed citations. Recurring topics across this work include Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Liver Diseases and Immunity (1 paper). The work is most often cited by research in Hepatology (14 citations), Epidemiology (22 citations) and Toxicology (2 citations). Julie C. Sung has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Gary Goldenberg, Linda Stein‐Gold, Leon Kircik, Ponni Perumalswami, Andrea D. Branch, Catherine Ong, Myron Schwartz, Douglas T. Dieterich, Fabrice Biot and Lian‐Hui Zhang. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Viral Hepatitis and Clinical Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.